Targeting myeloid-derived suppressor cells for cancer therapy
The emergence and clinical application of immunotherapy is considered a promising breakthrough in cancer treatment. According to the literature, immune checkpoint blockade (ICB) has achieved positive clinical responses in different cancer types, although its clinical efficacy remains limited in some...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
China Anti-Cancer Association
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/277836c16d664728bdeac45eeca03939 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|